Dachaigh › Neuroblastoma › Massachusetts
Sgrùdaidhean clionaigeach Neuroblastoma ann an Massachusetts
Tha 13 sgrùdaidhean airson Neuroblastoma a’ lorg phàirtichean aig làraichean ann an Massachusetts.
Bailtean ann an Massachusetts
Teacsa sgrùdaidh oifigeil (Beurla)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 3
Suas gu aois 30 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06172296MCT for the Harvard/UCSF ROBIN Center
- Brigham and Women's Hospital, Boston
A’ fastadh
Gach aois · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06000787Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Dana-Farber Cancer Institute ( Site 1013), Boston
A’ fastadhÌre 1/2
6 Months – 25 Years · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06395103B7-H3.CD28Z.CART in Solid Tumors
- Dana Farber Cancer Institite, Boston
A’ fastadhÌre 1
9 Months – 30 Years · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07358260Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 3
365 Days – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119SPEARHEAD-3 Pediatric Study
- Dana Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
Aoisean 2 gu 21 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05642455PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06721689NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Boston Children's Hospital, Dana-Farber Cancer Institute., Boston
A’ fastadhÌre 2
Aoisean 1 gu 31 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT06450041Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1
Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT07027748Neuroblastoma Biology Study
- Children's Hospital Boston, Boston
A’ fastadhSgrùdadh amharc
31 Days – 99 Years · Gach gnè · Air ùrachadh 23 Màrt 2026 · NCT01587300Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Dana-Farber Cancer Institute, Boston
A’ fastadh
Suas gu aois 17 · Gach gnè · Air ùrachadh 10 Gearr 2026 · NCT06831552Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
12 Months – 29 Years · Gach gnè · Air ùrachadh 26 Dùbh 2025 · NCT06803875Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.